Publication | Closed Access

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

Hematological MalignancyHealth SciencesPediatric HematologyMedicineMixed-phenotype Acute LeukemiaHematologyDiagnosisPathologyMyeloid NeoplasiaCytometryOncologyRadiologyClinical Significance